Intestinal organoids: The path towards clinical application

Organoids have revolutionized the whole field of biology with their ability to model complex three-dimensional human organs in vitro. Intestinal organoids were especially consequential as the first successful long-term culture of intestinal stem cells, which raised hopes for translational medical ap...

Full description

Saved in:
Bibliographic Details
Main Authors: Hady Yuki Sugihara, Ryuichi Okamoto, Tomohiro Mizutani
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:European Journal of Cell Biology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0171933524000918
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832590955539070976
author Hady Yuki Sugihara
Ryuichi Okamoto
Tomohiro Mizutani
author_facet Hady Yuki Sugihara
Ryuichi Okamoto
Tomohiro Mizutani
author_sort Hady Yuki Sugihara
collection DOAJ
description Organoids have revolutionized the whole field of biology with their ability to model complex three-dimensional human organs in vitro. Intestinal organoids were especially consequential as the first successful long-term culture of intestinal stem cells, which raised hopes for translational medical applications. Despite significant contributions to basic research, challenges remain to develop intestinal organoids into clinical tools for diagnosis, prognosis, and therapy. In this review, we outline the current state of translational research involving adult stem cell and pluripotent stem cell derived intestinal organoids, highlighting the advances and limitations in disease modeling, drug-screening, personalized medicine, and stem cell therapy. Preclinical studies have demonstrated a remarkable functional recapitulation of infectious and genetic diseases, and there is mounting evidence for the reliability of intestinal organoids as a patient-specific avatar. Breakthroughs now allow the generation of structurally and cellularly complex intestinal models to better capture a wider range of intestinal pathophysiology. As the field develops and evolves, there is a need for standardized frameworks for generation, culture, storage, and analysis of intestinal organoids to ensure reproducibility, comparability, and interpretability of these preclinical and clinical studies to ultimately enable clinical translation.
format Article
id doaj-art-5c561965e069451fb285dc4a21b46595
institution Kabale University
issn 0171-9335
language English
publishDate 2025-03-01
publisher Elsevier
record_format Article
series European Journal of Cell Biology
spelling doaj-art-5c561965e069451fb285dc4a21b465952025-01-23T05:26:16ZengElsevierEuropean Journal of Cell Biology0171-93352025-03-011041151474Intestinal organoids: The path towards clinical applicationHady Yuki Sugihara0Ryuichi Okamoto1Tomohiro Mizutani2Department of Gastroenterology and Hepatology, Institute of Science Tokyo, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113-8510, JapanDepartment of Gastroenterology and Hepatology, Institute of Science Tokyo, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113-8510, JapanCorresponding author.; Department of Gastroenterology and Hepatology, Institute of Science Tokyo, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113-8510, JapanOrganoids have revolutionized the whole field of biology with their ability to model complex three-dimensional human organs in vitro. Intestinal organoids were especially consequential as the first successful long-term culture of intestinal stem cells, which raised hopes for translational medical applications. Despite significant contributions to basic research, challenges remain to develop intestinal organoids into clinical tools for diagnosis, prognosis, and therapy. In this review, we outline the current state of translational research involving adult stem cell and pluripotent stem cell derived intestinal organoids, highlighting the advances and limitations in disease modeling, drug-screening, personalized medicine, and stem cell therapy. Preclinical studies have demonstrated a remarkable functional recapitulation of infectious and genetic diseases, and there is mounting evidence for the reliability of intestinal organoids as a patient-specific avatar. Breakthroughs now allow the generation of structurally and cellularly complex intestinal models to better capture a wider range of intestinal pathophysiology. As the field develops and evolves, there is a need for standardized frameworks for generation, culture, storage, and analysis of intestinal organoids to ensure reproducibility, comparability, and interpretability of these preclinical and clinical studies to ultimately enable clinical translation.http://www.sciencedirect.com/science/article/pii/S0171933524000918Intestinal organoidsClinical applicationPersonalized medicineDrug screeningRegenerative medicineTissue engineering
spellingShingle Hady Yuki Sugihara
Ryuichi Okamoto
Tomohiro Mizutani
Intestinal organoids: The path towards clinical application
European Journal of Cell Biology
Intestinal organoids
Clinical application
Personalized medicine
Drug screening
Regenerative medicine
Tissue engineering
title Intestinal organoids: The path towards clinical application
title_full Intestinal organoids: The path towards clinical application
title_fullStr Intestinal organoids: The path towards clinical application
title_full_unstemmed Intestinal organoids: The path towards clinical application
title_short Intestinal organoids: The path towards clinical application
title_sort intestinal organoids the path towards clinical application
topic Intestinal organoids
Clinical application
Personalized medicine
Drug screening
Regenerative medicine
Tissue engineering
url http://www.sciencedirect.com/science/article/pii/S0171933524000918
work_keys_str_mv AT hadyyukisugihara intestinalorganoidsthepathtowardsclinicalapplication
AT ryuichiokamoto intestinalorganoidsthepathtowardsclinicalapplication
AT tomohiromizutani intestinalorganoidsthepathtowardsclinicalapplication